2.35
price down icon1.67%   -0.04
after-market Dopo l'orario di chiusura: 2.32 -0.03 -1.28%
loading
Precedente Chiudi:
$2.39
Aprire:
$2.36
Volume 24 ore:
36,845
Relative Volume:
0.39
Capitalizzazione di mercato:
$95.81M
Reddito:
$2.70M
Utile/perdita netta:
$5.53M
Rapporto P/E:
-4.6078
EPS:
-0.51
Flusso di cassa netto:
$-10.55M
1 W Prestazione:
+2.62%
1M Prestazione:
+0.00%
6M Prestazione:
+0.00%
1 anno Prestazione:
+31.28%
Intervallo 1D:
Value
$2.34
$2.3703
Intervallo di 1 settimana:
Value
$2.31
$2.42
Portata 52W:
Value
$1.80
$3.67

Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile

Name
Nome
Oramed Pharmaceuticals Inc
Name
Telefono
646-844-1164
Name
Indirizzo
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Name
Dipendente
15
Name
Cinguettio
@OramedPharma
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
ORMP's Discussions on Twitter

Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2023-01-12 Downgrade Canaccord Genuity Buy → Hold
2022-02-18 Iniziato Cantor Fitzgerald Overweight
2021-04-20 Iniziato Canaccord Genuity Buy
2021-02-09 Iniziato National Securities Buy
2020-12-03 Iniziato Alliance Global Partners Buy
2020-03-11 Iniziato Aegis Capital Buy
2019-09-11 Iniziato Ladenburg Thalmann Buy
2017-12-11 Ripresa B. Riley FBR, Inc. Buy
2016-05-26 Reiterato FBR Capital Outperform
2015-12-01 Reiterato H.C. Wainwright Buy
2015-11-19 Iniziato FBR Capital Outperform
2015-04-13 Ripresa MLV & Co Buy
2014-01-30 Reiterato Aegis Capital Buy
2014-01-08 Reiterato Aegis Capital Buy
2014-01-08 Iniziato MLV & Co Buy
2013-12-03 Iniziato Aegis Capital Buy
Mostra tutto

Oramed Pharmaceuticals Inc Borsa (ORMP) Ultime notizie

pulisher
Oct 29, 2024

Oramed Announces Additional $1M Payment on Tranche A Note By Investing.com - Investing.com South Africa

Oct 29, 2024
pulisher
Oct 29, 2024

Oramed Announces Additional $1M Payment on Tranche A Note - Investing.com India

Oct 29, 2024
pulisher
Oct 22, 2024

Oramed Pharmaceuticals (NASDAQ:ORMP) Rating Increased to Buy at StockNews.com - MarketBeat

Oct 22, 2024
pulisher
Oct 14, 2024

Oramed Pharmaceuticals (NASDAQ:ORMP) Cut to "Hold" at StockNews.com - MarketBeat

Oct 14, 2024
pulisher
Oct 08, 2024

ORAMED PHARMACEUTICALS INC. Refinances with New Securities Purchase Agreement - MarketBeat

Oct 08, 2024
pulisher
Oct 08, 2024

Oramed Pharmaceuticals Reinforces Scilex Financial Ties - TipRanks

Oct 08, 2024
pulisher
Oct 07, 2024

Scilex Holding extends payment deadline in Oramed agreement - Investing.com India

Oct 07, 2024
pulisher
Oct 07, 2024

Oramed Pharmaceuticals Announces Restructuring of Scilex Holding Company Debt - PR Newswire

Oct 07, 2024
pulisher
Oct 07, 2024

Scilex Holding Company Announces Signing of a $50 Million - GlobeNewswire

Oct 07, 2024
pulisher
Oct 07, 2024

Scilex Holding Company Announces Signing of a $50 Million Registered Convertible Financing to Refinance and Restructure Existing Debt & Further Strengthens Financial Profile - Yahoo Finance

Oct 07, 2024
pulisher
Oct 04, 2024

Oramed Pharmaceuticals (NASDAQ:ORMP) Upgraded to Buy by StockNews.com - MarketBeat

Oct 04, 2024
pulisher
Oct 03, 2024

Tranche Update on Oramed Pharmaceuticals Inc.'s Equity Buyback Plan announced on June 26, 2024. - Marketscreener.com

Oct 03, 2024
pulisher
Sep 29, 2024

Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) Shares Bought by Murchinson Ltd. - MarketBeat

Sep 29, 2024
pulisher
Sep 26, 2024

Oramed signs $11.5 million deal for clinical trial services By Investing.com - Investing.com South Africa

Sep 26, 2024
pulisher
Sep 26, 2024

Oramed signs $11.5 million deal for clinical trial services - Investing.com

Sep 26, 2024
pulisher
Sep 26, 2024

Non-Alcoholic Steatohepatitis Pipeline Insights 2024: - openPR

Sep 26, 2024
pulisher
Sep 26, 2024

Non-Alcoholic Steatohepatitis Pipeline Insights 2024: Therapies, Clinical Trials, and MOA, ROA by DelveInsight | Viking Therapeutics, Seal Rock Therapeutics, AstraZeneca, Boehringer Ingelheim, Oramed - Barchart

Sep 26, 2024
pulisher
Sep 26, 2024

Oramed Pharmaceuticals (NASDAQ:ORMP) Downgraded by StockNews.com to Hold - MarketBeat

Sep 26, 2024
pulisher
Sep 24, 2024

Dianthus Therapeutics (NASDAQ:DNTH) and Oramed Pharmaceuticals (NASDAQ:ORMP) Financial Review - Defense World

Sep 24, 2024
pulisher
Sep 24, 2024

Murchinson Ltd. Trims Stock Holdings in Oramed Pharmaceuticals Inc. (NASDAQ:ORMP) - MarketBeat

Sep 24, 2024
pulisher
Sep 23, 2024

Scilex Holding agrees to payment terms with Oramed Pharmaceuticals - Investing.com India

Sep 23, 2024
pulisher
Sep 23, 2024

Oramed Pharmaceuticals (ORMP) Price Target Increased by 57.50% to 3.21 - MSN

Sep 23, 2024
pulisher
Sep 19, 2024

Moors & Cabot Inc. Buys 164 Shares of O’Reilly Automotive, Inc. (NASDAQ:ORLY) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Oriole Resources (LON:ORR) Shares Down 2.3% - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Sidoti Csr Weighs in on Orion Group Holdings, Inc.’s Q3 2024 Earnings (NYSE:ORN) - Defense World

Sep 19, 2024
pulisher
Sep 19, 2024

Oral Biologics Market 2024-2031 Industry Size Forecast: Growth - openPR

Sep 19, 2024
pulisher
Sep 18, 2024

O'Reilly Automotive, Inc. (NASDAQ:ORLY) Position Raised by E Fund Management Co. Ltd. - MarketBeat

Sep 18, 2024
pulisher
Sep 17, 2024

BMO Capital Markets analysts downgrades a Market perform rating for Ionis Pharmaceuticals Inc (IONS) - Knox Daily

Sep 17, 2024
pulisher
Sep 17, 2024

Wealthspire Advisors LLC Buys 12 Shares of O’Reilly Automotive, Inc. (NASDAQ:ORLY) - Defense World

Sep 17, 2024
pulisher
Sep 16, 2024

OMIC’s Market Whiplash: -10.31% YTD Decline, 69.47% Rise in 30 Days - The InvestChronicle

Sep 16, 2024
pulisher
Sep 14, 2024

Ashton Thomas Private Wealth LLC Takes Position in O’Reilly Automotive, Inc. (NASDAQ:ORLY) - Defense World

Sep 14, 2024
pulisher
Sep 14, 2024

O’Reilly Automotive, Inc. (NASDAQ:ORLY) Shares Purchased by Acadian Asset Management LLC - Defense World

Sep 14, 2024
pulisher
Sep 13, 2024

Private Advisor Group LLC Has $2.56 Million Stake in O’Reilly Automotive, Inc. (NASDAQ:ORLY) - Defense World

Sep 13, 2024
pulisher
Sep 12, 2024

Research Analysts Set Expectations for Oramed Pharmaceuticals Inc.'s Q3 2024 Earnings (NASDAQ:ORMP) - MarketBeat

Sep 12, 2024
pulisher
Sep 11, 2024

Oramed Pharmaceuticals (NASDAQ:ORMP) Downgraded by StockNews.com to “Hold” - Defense World

Sep 11, 2024
pulisher
Sep 11, 2024

Comprehensive Study of Oral Biologics Market 2024-2031 - openPR

Sep 11, 2024
pulisher
Sep 10, 2024

Oramed Pharmaceuticals (NASDAQ:ORMP) Downgraded to "Hold" at StockNews.com - MarketBeat

Sep 10, 2024
pulisher
Sep 10, 2024

Oramed Pharmaceuticals’ (ORMP) Neutral Rating Reaffirmed at HC Wainwright - Defense World

Sep 10, 2024
pulisher
Sep 09, 2024

H.C. Wainwright maintains Neutral rating on Oramed amid ongoing NMPA review - Investing.com India

Sep 09, 2024
pulisher
Sep 09, 2024

Oramed Pharmaceuticals (NASDAQ:ORMP) Stock Rating Reaffirmed by HC Wainwright - MarketBeat

Sep 09, 2024
pulisher
Sep 02, 2024

Brokers Offer Predictions for Oramed Pharmaceuticals Inc.'s Q3 2024 Earnings (NASDAQ:ORMP) - MarketBeat

Sep 02, 2024
pulisher
Aug 29, 2024

ORMP: Balance Sheet Strong, Potential Benefits of Investments, JVs, Buybacks - MSN

Aug 29, 2024
pulisher
Aug 28, 2024

Oramed Pharmaceuticals (NASDAQ:ORMP) Upgraded by StockNews.com to Buy - Defense World

Aug 28, 2024
pulisher
Aug 24, 2024

Oramed Pharmaceuticals (NASDAQ:ORMP) Share Price Crosses Below Two Hundred Day Moving Average of $2.58 - MarketBeat

Aug 24, 2024
pulisher
Aug 22, 2024

Future Scope of Oral Biologics Market Overall Study Report - openPR

Aug 22, 2024
pulisher
Aug 20, 2024

Oramed Pharmaceuticals (FRA:OJU1) 3-Year EPS without NRI Gr - GuruFocus.com

Aug 20, 2024
pulisher
Aug 19, 2024

Oramed Pharmaceuticals (FRA:OJU1) Net Income From Continuin - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

ORMP Stock Earnings: Oramed Pharmaceuticals Beats EPS for Q2 2024 - InvestorPlace

Aug 19, 2024
pulisher
Aug 19, 2024

Oramed Pharmaceuticals (FRA:OJU1) COGS-to-Revenue : 0.00 (As of Jun. 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

Oramed Pharmaceuticals (FRA:OJU1) GF Value Rank : 1 (As of Aug. 19, 2024) - GuruFocus.com

Aug 19, 2024
pulisher
Aug 19, 2024

ORMP (Oramed Pharmaceuticals) Purchase Of Investment : $-105.00 Mil (TTM As of Jun. 2024) - GuruFocus.com

Aug 19, 2024

Oramed Pharmaceuticals Inc Azioni (ORMP) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Capitalizzazione:     |  Volume (24 ore):